The gp130 / STAT3 signaling pathway mediates β-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes

FEBS Journal

Volumn 275, Issue 14, 2008, Pages 3590-3597

  Zhang, Hui ^a   Feng, Wei ^a   Liao, Wenqiang ^a   Ma, Xiaowei ^a   Han, Qide ^a   Zhang, Youyi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

adrenergic receptor; ANF; Cardiomyocytes; Gp130; STAT3

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; GLYCOPROTEIN GP 130; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

LENTIVIRUS; RATTUS;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; ISOPROTERENOL; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 50549087742     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06504.x     Document Type: Article

References (27)

1. Brodde OE & Michel MC (1999) Adrenergic and mus-carinic receptors in the human heart. Pharmacol Rev 51, 651-690.
2. Xiang Y & Kobilka BK (2003) Myocyte adrenoceptor signaling pathways. Science 300, 1530-1532.
3. Morisco C, Zebrowski DC, Vatner DE, Vatner SF, Sadoshima J & (2001) Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. J Mol Cell Cardiol 33, 561-573.
4. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM & Ritchie RH (2006) Anti-oxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat car-diomyocytes. Cardiovasc Res 72, 112-123.
5. Nishikimi T, Maeda N & Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69, 318-328.
6. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF & Sadoshima J (2000) The Akt-glycogen syn-thase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem 275, 14466-14475.
7. Yamauchi-Takihara K & Kishimoto T (2000) A novel role for STAT3 in cardiac remodeling. Trends Cardio-vasc Med 10, 298-303.
8. Hilfiker-Kleiner D, Hilfiker A & Drexler H (2005) Many good reasons to have STAT3 in the heart. Pharmacol Ther 107, 131-137.
9. Kodama H, Fukuda K, Pan J, Makino S, Sano M, Takahashi T, Hori S & Ogawa S (1998) Biphasic activation of the JAK ? STAT pathway by angiotensin II in rat cardiomyocytes. Circ Res 82, 244-250.
10. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K & Kishimoto T (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98, 346-352.
11. Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H & Nemer M (2005) Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 25, 9829-9844.
12. Wen Z, Zhong Z & Darnell JE Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
13. Lo RK, Cheung H & Wong YH (2003) Constitutively active Galpha16 stimulates STAT3 via a c-Src ? JAK-and ERK-dependent mechanism. J Biol Chem 278, 52154-52165.
14. Yin F, Li P, Zheng M, Chen L, Xu Q, Chen K, Wang YY, Zhang YY & Han C (2003) Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart. J Biol Chem 278, 21070-21075. 10
15. Hu LA, Chen W, Martin NP, Whalen EJ, Premont RT & Lefkowitz RJ (2003) GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. J Biol Chem 278, 26295-26301.
16. Aggeli IK, Gaitanaki C, Lazou A & Beis I (2002) Alpha(1)- and beta-adrenoceptor stimulation differentially activate p38-MAPK and atrial natriuretic peptide production in the perfused amphibian heart. J Exp Biol 205, 2387-2397.
17. Chung J, Uchida E, Grammer TC & Blenis J (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17, 6508-6516.
18. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S et al. (1999) Requirement for Ras ? Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 tran-scriptional activity induced by the Src oncoprotein. Mol Cell Biol 19, 7519-7528.
19. Yin F, Wang YY, Du JH, Li C, Lu ZZ, Han C & Zhang YY (2006) Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol 40, 384-393.
20. Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T & Yazaki Y (1999) Both Gs and Gi proteins are critically involved in isoproterenol-induced car-diomyocyte hypertrophy. J Biol Chem 274, 9760-9770.
21. Slack EC, Robinson MJ, Hernanz-Falcon P, Brown GD, Williams DL, Schweighoffer E, Tybulewicz VL & Reis e Sousa C (2007) Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur J Immunol 37, 1600-1612.
22. Souza CD, Evanson OA & Weiss DJ (2007) Role of the MAPK(ERK) pathway in regulation of cytokine expression by Mycobacterium avium subsp paratuberculosis-exposed bovine monocytes. Am J Vet Res 68, 625-630.
23. So H, Kim H, Lee JH, Park C, Kim Y, Kim E, Kim JK, Yun KJ, Lee KM, Lee HY et al. (2007) Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol 8, 338-355.
24. Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I & Azuma J (2005) STAT3 mediates cardioprotection against ischemia ? reperfusion injury through metallo-thionein induction in the heart. Cardiovasc Res 65, 428-435.
25. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, Schneider M et al. (2003) Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci USA 100, 12929-12934.
26. Edwards JG (2006) In vivo beta-adrenergic activation of atrial natriuretic factor (ANF) reporter expression. Mol Cell Biochem 292, 119-129.
27. Liao W, Wang S, Han C & Zhang Y (2005) 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J 272, 1845-1854.